Inhaled corticosteroid use during pregnancy among women with asthma: A systematic review and meta-analysis.

Annelies L RobijnMegan E JensenKaren McLaughlinPeter Gerard GibsonVanessa E Murphy
Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2019)
The prevalence of ICS use among pregnant women with asthma is 41% and varies widely between countries and continents, and prescription rates for ICS change throughout pregnancy. More studies are needed to investigate ICS adherence during pregnancy in women with asthma.